SCHEMBL4150992

SCHEMBL4150992

COc1ccc2c(c1)CCc1ccccc1/C2=C\c1cccc(O)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 7/20 0.56
MEN1 O00255 2/20 0.56
MAPT P10636 2/20 0.56
KMT2A Q03164 2/20 0.56
NPC1 O15118 1/20 0.56
PKM P14618 1/20 0.56
RAB9A P51151 1/20 0.56
ATM Q13315 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
AR P10275 3/20 0.53
TUBB4A P04350 1/20 0.53
TUBB P07437 1/20 0.53
TUBA3C P0DPH7 1/20 0.53
TUBA1B P68363 1/20 0.53
TUBA4A P68366 1/20 0.53
TUBB4B P68371 1/20 0.53
TUBB3 Q13509 1/20 0.53
TUBB2A Q13885 1/20 0.53
TUBB8 Q3ZCM7 1/20 0.53
TUBA3E Q6PEY2 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4150994 1.00 MIF (0.56) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4167935 0.95 MIF (0.54) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4163634 0.89 MIF (0.64) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4163632 0.89 MIF (0.64) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4037187 0.87 MIF (0.67) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4157857 0.86 MAPT (0.55) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4042210 0.85 KMT2A (0.69) MIFMEN1MAPTKMT2ANPC1
SCHEMBL4157852 0.84 MAPT (0.53) MIFMEN1MAPTKMT2ANPC1
SCHEMBL8348970 0.82 MIF (0.55) MIFMEN1KMT2AARTUBB4A
SCHEMBL4156050 0.82 MIF (0.55) MIFMEN1KMT2AARTUBB4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS COGHLAN MICHAEL JOSEPH 2009-06-11 US disclosed
US-7411072-B2 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY (US) 2008-08-12 US disclosed
US-20060063759-A1 Tricyclic steroid hormone nuclear receptor modulators ELI LILLY AND COMPANY 2006-03-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149445-A1 TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS NR5A1, NR3C2, NR3C1 MIF 1642/4885MEN1 2935/4885MAPT 3591/4885
US-20060063759-A1 Tricyclic steroid hormone nuclear receptor modulators NR5A1, NR3C2, NR3C1 MIF 1592/4885MEN1 2716/4885MAPT 3416/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.